ART Fertility Clinics LLC
Abu Dhabi, 60202, United Arab Emirates
NCT Number: NCT04417569
This study will determine the rise of progesterone levels after human chorionic gonadotrophin (hCG) trigger in stimulated cycles IVF/ICSI
Looking for future studies?
Notify Me18 year–42 year
Female
Observational
Abu Dhabi, 60202, United Arab Emirates
Studies have suggested that controlled ovarian hyperstimulation adversely affects endometrial receptivity. In ovarian stimulation cycles with exogenous gonadotrophins there is an ongoing debate regarding the effect of a late follicular phase progesterone level on reproductive outcomes. It is not yet clarified if an elevated serum progesterone level in the late follicular phase is a symptom or cause of an adverse effect on reproductive outcomes. A new hypothesis is evolving and gaining momentum providing a novel explanation for the association between late follicular phase progesterone rise and reproductive outcome. It is proposed that exogenous FSH (Follicle-stimulating hormone) administration results in supraphysiological levels of FSH, which induce an abundance of LH (luteinizing hormone) receptors on granulosa cells causing the follicles to become hypersensitive to LH-like activity (ie hCG trigger). Based on this hypothesis, the focus should be placed on the hCG trigger rather than on the late follicular phase progesterone rise.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
human chorionic gonadotropin
Other names: human chorionic gonadotropin
Endometrial thickness monitoring
Other names: transvaginal scan
Progesterone, Luteinizing Hormone, Estradiol
Other names: Progesterone, Luteinizing Hormone, Estradiol
Time frame: 1 day
day of the hCG trigger between 1000h - 1200h, before trigger, 1 hour after trigger, 2 hrs after trigger
Time frame: 1 day
36hrs after trigger
ART Fertility Clinics LLC
Other
A Proof of Concept Study to Determine the Rise of Progesterone Levels After Human Chorionic Gonadotrophin (hCG) Trigger in Stimulated Cycles of IVF/ICSI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04170517
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Birmingham, United Kingdom
View Trial DetailsNCT06419127
Aneuploidy, Chromosome Aberrations
Fort Lauderdale, Florida, United States
View Trial DetailsNCT03712982
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Waltham, Massachusetts, United States
View Trial DetailsNCT07288866
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Clermont-Ferrand, Auvergne, France
View Trial Details